Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian Cancer
Volume
75
Pagination
1255 - 1264
DOI
10.1158/0008-5472.CAN-14-1801
Journal
CANCER RESEARCH
Issue
ISSN
0008-5472